What question did this study set out to answer?

This research evaluates the feasibility of sleep screening in adolescents with type 1 diabetes (T1D) and their health care providers (HCPs).

June 7, 2026

1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility

Key Points

This research evaluates the feasibility of sleep screening in adolescents with type 1 diabetes (T1D) and their health care providers (HCPs).
Participants included adolescents aged 11-17 with T1D and HCPs who completed a sleep screening survey.
The survey included PROMIS Sleep-Related Impairment and Sleep Disturbance scales, followed by feasibility questions.
Both groups provided insights on the acceptability and utility of sleep screenings in routine diabetes care.
96% of adolescents found the screening feasible during clinic check-in, with 73% preferring this method.
62% of adolescents assessed the screening as helpful, while 64% valued discussions about sleep with HCPs.
87% of HCPs noted that patients reported sleep concerns, with 73% estimating the time needed to discuss results.

Abstract

Introduction and Objective: Sleep disturbances are common among adolescents with T1D and impact glycemic management and quality of life. Sleep health is rarely assessed in routine care. We evaluated sleep screening feasibility in adolescents and pediatric diabetes HCPs. Methods: Adolescents with T1D (ages 11-17) and HCPs completed or reviewed a sleep screening survey including the PROMIS Sleep-Related Impairment and Sleep Disturbance 4-item scales, followed by questions focused on causes of sleep concerns and feasibility (table). Results: Among adolescents (N=111, mean age 14.7±2.2yrs), mean completion time was 6.6±4.4 mins. 96% indicated feasibility during clinic check-in, which was also the preferred method (73%). 62% endorsed the screening as helpful in routine diabetes care and 64% valued discussing sleep with HCPs. Among HCPs (N=15), 87% reported patients endorsing sleep concerns. 60% indicated sufficient time to address sleep during visits. 73% estimated needing 1-9 min to discuss results. Preferred resources included patient handouts (100%), referral advice (87%), and diabetes management advice (87%). Conclusion: Adolescents with T1D and HCPs found a brief sleep screening survey feasible, acceptable, and clinically relevant. Integrating sleep screening into diabetes care may facilitate identification of sleep concerns and support targeted interventions to improve adolescent well-being and diabetes management. Disclosure E. Cobry: None. E. Fivekiller: None. L.J. Meltzer: Consultant; Current; Egetis Therapeutics, Zepp Health. S. Jaser: Speaker's Bureau; Ended; Sanofi. B. Stewart: None. R.P. Wadwa: Advisory Panel; Current; Medtronic. Advisory Panel; Ended; Tandem Diabetes Care, Inc. Consultant; Ended; Tandem Diabetes Care, Inc. Research Support; Current; Tandem Diabetes Care, Inc. Consultant; Ended; Dexcom, Inc. Research Support; Ended; Dexcom, Inc. Funding Breakthrough T1D (5-ECR-2022-1179-A-N)

Bookmark

1567-P: Clinical Sleep Screening for Adolescents with Type 1 Diabetes (T1D): Adolescent and Health Care Provider (HCP) Perspectives on Feasibility

Key Points

Abstract

Cite This Study

Also Consider

Also Consider